Target- |
MechanismImmunostimulants |
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.DE |
First Approval Date12 Jun 2002 |
100 Clinical Results associated with Sanofi Pasteur MSD GmbH (Germany)
0 Patents (Medical) associated with Sanofi Pasteur MSD GmbH (Germany)
100 Deals associated with Sanofi Pasteur MSD GmbH (Germany)
100 Translational Medicine associated with Sanofi Pasteur MSD GmbH (Germany)